Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...

in which it stated that “GARDASIL/GARDASIL 9 [s]ales [d]eclined 3% to $8.6 Billion.” In addition, the current report stated Merck’s “decision to temporarily pause shipments of GARDASIL ...

Recently appointed HHS Secretary Robert F. Kennedy Jr. in 2018 helped bring several cases against vaccine maker Merck, alleging injury linked to its HPV shot Gardasil. Merck and a plaintiff suing the ...

Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the ...

Merck (NSE:PROR) & Co., Inc. (NYSE: MRK), a global healthcare giant, finds itself at a critical juncture as it navigates challenges in its Gardasil vaccine ... at $8.88 to $9.03, approximately ...

Trial adjourned, new jury due to reconvene in September Kennedy helped organize litigation against Merck before HHS role Merck denies claims, cites scientific evidence supporting Gardasil safety ...

hit a record high on Wednesday after it posted a 9% rise in fourth-quarter net profit that beat expectations and announced a S$3 billion ($2.24 billion) package to return surplus capital to investors.

PHAC recommends that immunocompromised individuals — including people living with HIV — receive three-dose schedule of the Gardasil-9 vaccine. It estimates that 25 to 35 per cent of mouth ...